Enanta Pharmaceuticals, Inc. (ENTA)

Enanta Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Market Capitalization	197	235	1,075	1,148	919	1,182
Market Cap Growth	-39.04%	-78.12%	-6.39%	24.98%	-22.29%	-28.59%
Enterprise Value	146	73	809	784	494	795
Last Close Price	9.08	11.17	51.87	56.81	45.78	60.08
PE Ratio	-	-	-	-	-	25.49
PS Ratio	2.67	2.97	12.48	11.83	7.50	5.76
PB Ratio	1.29	1.09	3.35	2.88	2.02	2.56
P/TBV Ratio	1.84	1.09	3.35	2.88	2.02	2.56
P/FCF Ratio	-	-	-	-	162.84	17.92
P/OCF Ratio	-	-	-	-	129.64	16.56
EV/Sales Ratio	2.03	0.93	9.38	8.08	4.03	3.87
EV/EBITDA Ratio	-	-	-	-	-	19.88
EV/EBIT Ratio	-	-	-	-	-	21.64
EV/FCF Ratio	-	-	-	-	87.53	12.05
Debt / Equity Ratio	1.52	1.03	0.08	0.02	0.02	0.00
Debt / EBITDA Ratio	-	-	-	-	-	0.05
Debt / FCF Ratio	-	-	-	-	1.70	0.03
Asset Turnover	0.16	0.19	0.21	0.21	0.25	0.45
Quick Ratio	4.65	6.52	10.00	8.43	17.52	17.10
Current Ratio	4.92	6.73	10.45	8.82	18.08	17.77
Return on Equity (ROE)	-59.64%	-49.74%	-33.78%	-18.48%	-7.88%	10.83%
Return on Assets (ROA)	-17.18%	-20.47%	-19.01%	-14.81%	-5.33%	5.08%
Return on Capital (ROIC)	-18.20%	-21.79%	-20.52%	-15.72%	-5.60%	5.34%
Earnings Yield	-59.29%	-56.90%	-11.33%	-6.88%	-3.94%	3.92%
FCF Yield	-51.58%	-47.71%	-8.08%	-6.16%	0.61%	5.58%
Buyback Yield / Dilution	-1.10%	-1.78%	-2.14%	-1.16%	4.90%	-1.54%
Total Shareholder Return	-1.10%	-1.78%	-2.14%	-1.16%	4.90%	-1.54%

Source: S&P Capital IQ. Standard template. Financial Sources.